Constellation Brands Lets Canopy Growth Warrants Expire Unexercised

Constellation Brands (NYSE: STZ) appears to have walked away from the idea of investing further dollars into Canopy Growth (TSX: WEED). The company on Wednesday saw its Tranche A warrants held in the company expire, ending future investment opportunities in the company under its original investment agreement from 2018.

As of November 1, 88.5 million Tranche A warrants, which contained an exercise price of $50.40, have expired unexercised. While it was rather obvious that the warrants would not be exercised at this price, given the company closed Wednesday’s session at just $0.83 per share, it’s noteworthy that Constellation was seemingly disinterested in revising the warrant pricing prior to expiry.

With the Tranche A warrants expiring unexercised, the vesting terms of Tranche B warrants, which contain an exercise price of $76.68 per share, were not met, and as a result have expired as well. 12.8 million Tranche C warrants have likewise expired. Collectively, the three tranches of warrants would have enabled Constellation to increase its stake in the cannabis operator by a combined 16.9%.

As of Friday’s close, Constellation, through Greenstar Canada Investment Limited Partnership, owns 171.5 million shares of Canopy as well as $100.0 million in principal of promissory notes due 2024.

It’s been a painful trip for Canopy investors.

Constellation initially invested $5.0 billion in Canopy back in 2018, in what was a cornerstone investment for the cannabis industry as a whole. The investment at the time resulted in the company owning a 37% stake in the issuer, and with related warrants provided a path for the beverage alcohol company to secure a majority stake in Canopy.

READ: Canopy Growth Collects $53 Million From Sale Of Hershey Drive Facility

Continued failures by Canopy however have forced Constellation to take writedowns on its investment, with Constellation recording over $1.0 billion in impairments in a single quarter last year. Canopy Growth meanwhile, despite the several billion investment, today has a market valuation of just $713 million, and as of June 30 had a cash balance of just $533.3 million.

Canopy Growth last traded at $0.86 on the TSX.


Information for this briefing was found via Sedar and the sources mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Canada Should Be as Rich as Saudi Arabia. But It’s Not! | Michael Gentile

Artemis Gold Q3 Earnings: Growth Already In Focus

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

Recommended

Kalshi Faces Class Action Lawsuit Over Alleged Illegal Sports Betting

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Related News

Are Big Liquor And Tobacco Bankrolling Cannabis, Or Killing It?

Markets have been unkind to cannabis investors, and made certain fundamentals-based business bloggers, who were...

Saturday, June 6, 2020, 12:13:26 PM

Canopy Growth Loans TerrAscend C$80.5 Million

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) announced this morning that it has made a...

Wednesday, March 11, 2020, 08:39:07 AM

Canopy Growth’s Bruce Linton Finds Himself in a Catch-22

Canopy Growth Corp’s (TSX: WEED) (NYSE: CGC) Bruce Linton came under fire yesterday across social...

Friday, June 28, 2019, 09:22:46 AM

Canopy Sees Q2 Revenue Fall 36% Following BioSteel Bankruptcy

Canopy Growth (TSX: WEED) is now describing itself as an “asset-light” company following the release...

Friday, November 10, 2023, 08:51:31 AM

Canopy Growth, Hemp Producer Head to Court Over 1,115 Acres of Lost Production

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) and its US based hemp partner Go Farm...

Thursday, October 10, 2019, 04:22:24 PM